the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Last Updated on August 22, 2016 by Joseph Gut – thasso Sacco K, Grech G EPMA J 2015;6(1):15 PMID: 26203310 Abstract Breast cancer is a heterogeneous disease that necessitates proper patient classification to direct surgery, pharmacotherapy, and radiotherapy. Despite patients …
Actionable pharmacogenetic markers for prediction and prognosis in breast cancer Read more »
Last Updated on August 21, 2016 by Joseph Gut – thasso [avatar user=”thassodotcom” size=”thumbnail” align=”left” /] August 19, 2016 – We at thasso believe that on a worldwide scale, both, most modern principles of theragenomic and personalized medicine and traditional medicines …
Ayurveda: Knowledge of Pharmacogenomics in Indian Traditional Medicine Read more »
Last Updated on August 16, 2016 by Joseph Gut – thasso August 16, 2016 – Riociguat (Adempas) is a stimulator of soluble guanylate cyclase (sGC). In Canada, it is approved for and indicated in the treatment of pulmonary hypertension (PH) in three forms: inoperable chronic …
Patient Safety: Contraindication for Riociguat (Adempas) Read more »
Last Updated on August 14, 2016 by Joseph Gut – thasso August 14, 2016 – The PubMed-article below illustrates how pharmacogenetics and/or pharmacogenomics-guided drug therapy (i.e., theragenomic medicine) has its place and impact on patients and healthcare systems in African …
Last Updated on August 9, 2016 by Joseph Gut – thasso Huerta MC, Borgonovi F Soc Sci Med 2010 Jul;71(1):143-51 PMID: 20452109 Education, alcohol use and abuse among young adults in Britain Abstract In this article we explore the relationship …
Are young and highly educated women future heavy drinkers? Read more »
Last Updated on August 8, 2016 by Joseph Gut – thasso August 08, 2016 –The following publication has just been released by the EMA. Because Thasso Post is not only about theragenomic and personalized medicine, but also about the safety …
Patient safety: EMA recommends suspension of medicines over flawed studies Read more »
Last Updated on August 1, 2016 by Joseph Gut – thasso August 01, 2016 – Type 2 diabetes affects more than 29 million people and accounts for more than 90 percent of diabetes cases diagnosed in the United States. Over …
Lixisenatide (Adlyxin) approved to treat type 2 diabetes Read more »
Last Updated on July 27, 2016 by Joseph Gut – thasso July 26, 2016 – Renal cell carcinoma is the most common form of kidney cancer in adults. Advanced renal cell carcinoma includes both metastatic disease and locally advanced renal …
Cabometyx and Kisplyx: Two new medicines for advanced kidney cancer Read more »
Last Updated on July 12, 2016 by Joseph Gut – thasso July 12, 2016 – The American Food & Drug Administration (FDA) has notified Juno Therapeutics Inc. that a clinical hold has been placed on the Phase II clinical trial of …
Immunemodulation: Cancer drug trial halted after three test subjects die Read more »
Last Updated on July 11, 2016 by Joseph Gut – thasso July 9, 2016 – This is a huge step into the future of theragenomic and personalized medicine and individualized drug safety. In support of the President’s Precision Medicine Initiative …
Precision Medicine Initiative: draft guidances issued Read more »